All the news Showing 10 of 87 articles from: NAFLDGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Costs Balloon after Cirrhosis Diagnosis for NAFLD/NASH MedPage Today Gastroenterology / 17 April 2018 'Wake-up call' over liver disease risks due to weight BBC News / 17 April 2018 Cenicriviroc treatment improves liver fibrosis in people with NASH Liz Highleyman / 13 April 2018 Cenicriviroc, a drug that blocks both CCR5 and CCR2 receptors on immune cells, continued to show an anti-fibrotic effect in people with non-alcoholic steatohepatitis (NASH) after two years of follow-up, according to a ... Mediterranean diet reduces liver fat, risk for NAFLD Healio Hepatology / 03 April 2018 NAFLD May Be Easier to Prevent than Treat MedPage Today / 03 April 2018 Alcohol consumption and metabolic factors act together to increase the risk of severe liver disease Eurekalert Medicine & Health / 22 November 2017 Fatty Liver Common After Direct-Acting Antivirals for Hep C Medscape (requires free registration) / 01 November 2017 New EACS treatment guidelines Keith Alcorn / 31 October 2017 Everyone with HIV and hepatitis C virus (HCV) co-infection should receive direct-acting antiviral treatment for hepatitis C and should receive the same treatment for hepatitis C as people with hepatitis C monoinfection, ... Experimental therapy improves liver fat and fibrosis in people with NASH Liz Highleyman / 30 October 2017 GS-0976, an acetyl-CoA carboxylase (ACC) inhibitor being developed by Gilead Sciences, led to significant reductions in liver fat accumulation and fibrosis in people with non-alcoholic steatohepatitis (NASH), according to phase 2 study results ... Women with fatty liver disease at higher risk for heart disease Liz Highleyman / 24 October 2017 Women with non-alcoholic fatty liver disease (NAFLD) had a higher risk of cardiovascular events including chest pain and heart failure compared to women without the condition – and about the same risk as ... ← Prev1...56789Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD NASH Experimental treatments for NASH/NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds